API Synthesis and Manufacturing, Large Molecule

Aug 16, 2018
By BioPharm International Editors
FDA grants support US research in continuous manufacturing monitoring and control techniques for bio/pharmaceutical manufacturing at Rutgers, MIT, and Georgia Tech.
Aug 08, 2018
By BioPharm International Editors
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
Aug 01, 2018
BioPharm International
The changing regulatory and manufacturing environment is ushering in a new approach to drug development.
Aug 01, 2018
BioPharm International
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
Jul 19, 2018
By BioPharm International Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
Jul 18, 2018
By BioPharm International Editors
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
Jul 09, 2018
By BioPharm International Editors
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
Jul 01, 2018
BioPharm International
Late-stage and commercial biomanufacturing pose a challenge to cell-culture processing.
Jun 25, 2018
By BioPharm International Editors
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
Jun 15, 2018
BioPharm International
Biosimilars and biobetters have their own unique manufacturing strategies and challenges.
native1_300x100
lorem ipsum